We are live on ! Find out more
BT

Banque Transatlantique Portfolio holdings

AUM $4.66B
1-Year Est. Return 33.26%
This Fund
S&P 500
This Quarter Est. Return
-4.01%
1 Year Est. Return
+33.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.17B
AUM Growth
+$45.4M
Cap. Flow
+$360M
Cap. Flow %
8.64%
Top 10 Hldgs %
59%
Holding
452
New
193
Increased
101
Reduced
71
Closed
10

Top Buys

Rank Stock Value
1
TT icon
Trane Technologies
TT
+$79.2M
2
CRH icon
CRH
CRH
+$66.2M
3
ETN icon
Eaton
ETN
+$36.3M
4
TSM icon
TSMC
TSM
+$35.4M
5
AVGO icon
Broadcom
AVGO
+$35.4M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$33M
2
LLY icon
Eli Lilly
LLY
+$23.7M
3
HD icon
Home Depot
HD
+$19M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$18.8M
5
META icon
Meta Platforms (Facebook)
META
+$18M

Sector Composition

Rank Sector Weight
1 Technology 38.72%
2 Consumer Discretionary 12.97%
3 Communication Services 10.13%
4 Healthcare 8.84%
5 Consumer Staples 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ULTA icon
451
Ulta Beauty
ULTA
$24.3B
– –
-718
Closed -$435K
GRAL
452
GRAIL Inc
GRAL
$3.1B
– –
-23,000
Closed -$1.97M
15 16 17 18
19

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Banque Transatlantique's Q1 2026 Portfolio in Review

As of Q1 2026, Banque Transatlantique held 452 positions worth $4.17B, up 1.1% from $4.13B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Banque Transatlantique deployed $360M of net new capital in Q1 2026, opening 193 new positions and adding to 101 existing holdings. Its largest new stake was HCA Healthcare: 24,502 shares worth $11.7M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Boston Scientific, an estimated $33M trimmed.

  • Banque Transatlantique's largest Q1 2026 buy was HCA Healthcare: 24,502 shares worth $11.7M.
  • Banque Transatlantique added most to Trane Technologies in Q1 2026, an estimated $79.2M increase.
  • Banque Transatlantique's biggest Q1 2026 reduction was Boston Scientific, cutting an estimated $33M.
  • Banque Transatlantique fully exited GRAIL Inc in Q1 2026, selling an estimated $1.97M.
  • Banque Transatlantique's ten largest holdings make up 59% of its $4.17B portfolio in Q1 2026.
  • Banque Transatlantique opened 193 new positions and closed 10 in Q1 2026.
  • Banque Transatlantique's portfolio value rose 1.1% quarter-over-quarter to $4.17B.

Based on Banque Transatlantique's 13F filing for Q1 2026, filed 13 May 2026.